Medicare Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The "July effect" on patients admitted with diabetes ketoacidosis: a national retrospective cohort study
CONCLUSIONS: In this retrospective cohort study of patients admitted with DKA, inpatient care during July and August did not increase the odds of inpatient mortality.PMID:38628343 | PMC:PMC11018014 | DOI:10.1080/08998280.2024.2307833 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Garry Francis-Morel Nehemias Guevara-Rodriguez Shellsea Portillo-Canales Carlos Ernesto Arias Morales David Sotello Source Type: research

Understanding the financial cost of cancer clinical trial participation
ConclusionCancer clinical trial-related financial hardship, most often stemming from travel expenses, affected almost half of trial-enrolled patients. Interventions are needed to reduce adverse financial participation effects and potentially improve cancer clinical trial participation. (Source: Cancer Medicine)
Source: Cancer Medicine - April 17, 2024 Category: Cancer & Oncology Authors: Courtney P. Williams, Luqin Deng, Nicole E. Caston, Kathleen Gallagher, Rebekah Angove, Maria Pisu, Andres Azuero, Rebecca Arend, Gabrielle B. Rocque Tags: RESEARCH ARTICLE Source Type: research

Declining Inflation-Adjusted Medicare Physician Fees: An Unsustainable Trend in Hip Arthroscopy
DISCUSSION: Medicare reimbursement for all seven of the commonly used hip arthroscopy services did not keep up with inflation, demonstrating marked reductions from 2011 to 2021. Specifically, the inflation-adjusted reimbursements decreased between 19.23% and 24.69% between 2011 and 2021.PMID:38626441 | DOI:10.5435/JAAOS-D-23-00080 (Source: The Journal of the American Academy of Orthopaedic Surgeons)
Source: The Journal of the American Academy of Orthopaedic Surgeons - April 16, 2024 Category: Orthopaedics Authors: Andrew G Kim Adam A Rizk Jason G Ina Steven J Magister Michael J Salata Source Type: research

Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer
CONCLUSIONS: Patients with resected, stage II-III NSCLC who received neoadjuvant chemo/chemoradiotherapy have high rates of disease recurrence and poor survival outcomes, highlighting need for more effective treatments to improve survival rates.PMID:38627155 | DOI:10.1016/j.cllc.2024.03.006 (Source: Clinical Lung Cancer)
Source: Clinical Lung Cancer - April 16, 2024 Category: Cancer & Oncology Authors: Jessica Donington Xiaohan Hu Su Zhang Yan Song Ashwini Arunachalam Diana Chirovsky Chi Gao Ari Lerner Anya Jiang James Signorovitch Ayman Samkari Source Type: research

Disparities in postpartum readmission by patient- and hospital-level social risk factors in the United States: A retrospective multistate analysis, 2015-2020
The leading cause of hospital admission in the United States is related to pregnancy and delivery, accounting for nearly 4 million hospitalizations and costing $16.1 billion annually.1,2 Postpartum readmission following discharge from childbirth hospitalization has become a potential area of focus for improving the quality of obstetric care and reducing costs.3 However, unlike the United States Centers for Medicare& Medicaid Services ’ Hospital Readmissions Reduction Program (HRRP), which consists of six specific condition or procedure-related readmission measures primarily occurring among the older patient population, a...
Source: International Journal of Obstetric Anesthesia - April 16, 2024 Category: Anesthesiology Authors: Briana Lui, Elizabeth Khusid, Virginia E. Tangel, Silis Y. Jiang, Sharon E. Abramovitz, Corrina M. Oxford, Robert S. White Tags: Original Article Source Type: research

What is Happening in the Ambulatory Space? Past Challenges and Future Directions
Despite reimbursement pressures and scrutiny on procedural appropriateness, the demand for peripheral vascular ambulatory services remains strong. Improvements in minimally-invasive technologies, coupled with a supportive regulatory environment and considerable preference for ambulatory services among purchasers, patients, and providers, have resulted in the rapid proliferation of ambulatory facilities in a number of markets. Emerging ecosystem dynamics, notably the rapid growth of Medicare Advantage and the growing presence of private equity and venture capital within healthcare, will likely have an impact on future growt...
Source: Techniques in Vascular and Interventional Radiology - April 15, 2024 Category: Radiology Authors: Aaron Pascal Mauck Source Type: research

The Inflation Reduction Act: An Opportunity to Accelerate Confidence in US Real-World Evidence.
The objective of this commentary is to explore the implications of the IRA for US pharmaceutical companies, with a specific focus on the role of real-world evidence (RWE) in the context of Medicare reforms. (Source: Value in Health)
Source: Value in Health - April 15, 2024 Category: International Medicine & Public Health Authors: Paul Arora, Alind Gupta, Emma Mackay, Bart Heeg, Kristian Thorlund Source Type: research

Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value
Conclusion: IMPERIAL data suggest initial treatment with Eluvia extends the time patients spend without undergoing reintervention. This extension may be associated with cost savings in relevant time frames.PMID:38606556 | DOI:10.57264/cer-2024-0025 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - April 12, 2024 Category: General Medicine Authors: William A Gray Yoshimitsu Soga Masahiko Fujihara Osamu Iida Anvar Babaev Daizo Kawasaki Thomas Zeller David O'Connor Michael R Jaff Anna M Chavez Stefan M üller-Hülsbeck Source Type: research

Exploring kidney dialysis costs in the United States: a scoping review
CONCLUSIONS: These findings indicate that prevention of or delay in progression to ESRD could have considerable cost savings for Medicare and private payers, particularly in patients with high-risk conditions such as type 2 diabetes. More efficient use of resources is needed, including low-cost medication, to improve clinical outcomes and lower overall costs, especially in high-risk groups. Widening access to PD where it is safe and appropriate may help to reduce dialysis costs.PMID:38605648 | DOI:10.1080/13696998.2024.2342210 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - April 12, 2024 Category: Health Management Authors: Fiona Stewart Kristin Kistler Yuxian Du Rakesh R Singh Bonnie B Dean Sheldon X Kong Source Type: research